HK1004375A1 - Transdermal system for the simultaneous delivery of a number of active principles - Google Patents

Transdermal system for the simultaneous delivery of a number of active principles

Info

Publication number
HK1004375A1
HK1004375A1 HK98103763A HK98103763A HK1004375A1 HK 1004375 A1 HK1004375 A1 HK 1004375A1 HK 98103763 A HK98103763 A HK 98103763A HK 98103763 A HK98103763 A HK 98103763A HK 1004375 A1 HK1004375 A1 HK 1004375A1
Authority
HK
Hong Kong
Prior art keywords
amount
pct
active principles
therapeutic dose
effective therapeutic
Prior art date
Application number
HK98103763A
Other languages
English (en)
Inventor
Bruno Bevan
Cecile Aillaud
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of HK1004375A1 publication Critical patent/HK1004375A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
HK98103763A 1994-12-21 1998-05-04 Transdermal system for the simultaneous delivery of a number of active principles HK1004375A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415416A FR2728463A1 (fr) 1994-12-21 1994-12-21 Systeme transdermique d'administration simultanee de plusieurs principes actifs
PCT/FR1995/001696 WO1996019203A1 (fr) 1994-12-21 1995-12-19 Systeme transdermique d'administration simultanee de plusieurs principes actifs

Publications (1)

Publication Number Publication Date
HK1004375A1 true HK1004375A1 (en) 1998-11-27

Family

ID=9470067

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103763A HK1004375A1 (en) 1994-12-21 1998-05-04 Transdermal system for the simultaneous delivery of a number of active principles

Country Status (24)

Country Link
US (1) US5919477A (de)
EP (1) EP0800386B1 (de)
JP (1) JPH10510823A (de)
KR (1) KR980700071A (de)
CN (1) CN1072929C (de)
AT (1) ATE173164T1 (de)
AU (1) AU692042B2 (de)
CA (1) CA2208374A1 (de)
CZ (1) CZ183297A3 (de)
DE (1) DE69506007T2 (de)
DK (1) DK0800386T3 (de)
ES (1) ES2125679T3 (de)
FI (1) FI972542A (de)
FR (1) FR2728463A1 (de)
HK (1) HK1004375A1 (de)
HU (1) HUT77384A (de)
NO (1) NO972467L (de)
NZ (1) NZ298826A (de)
PL (1) PL182452B1 (de)
RU (1) RU2157193C2 (de)
SI (1) SI0800386T1 (de)
SK (1) SK280631B6 (de)
UA (1) UA42806C2 (de)
WO (1) WO1996019203A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69901927T2 (de) 1998-04-27 2002-10-10 Surmodics, Inc. Bioaktive wirkstoffe freisetzende beschichtungen
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US7243788B2 (en) * 2003-10-22 2007-07-17 Kimberly-Clark Worldwide, Inc. Package for segregating and mixing substances
MEP23508A (en) * 2003-10-28 2010-06-10 Noven Pharma Compositions and methods for comtrolling drug loss and delivery in transdermal drug delivery systems
WO2005097228A2 (en) 2004-04-06 2005-10-20 Surmodics, Inc. Coating compositions for bioactive agents
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
EP3936133A1 (de) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natürliche kombinationshormonersatzformulierungen und therapien
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2888241C (en) 2012-10-16 2020-12-29 Surmodics, Inc. Wound packing device and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator

Also Published As

Publication number Publication date
JPH10510823A (ja) 1998-10-20
UA42806C2 (uk) 2001-11-15
NO972467L (no) 1997-06-17
MX9704527A (es) 1997-10-31
SI0800386T1 (en) 1999-04-30
SK79197A3 (en) 1997-12-10
FR2728463A1 (fr) 1996-06-28
AU692042B2 (en) 1998-05-28
WO1996019203A1 (fr) 1996-06-27
ATE173164T1 (de) 1998-11-15
CZ183297A3 (en) 1997-10-15
KR980700071A (ko) 1998-03-30
US5919477A (en) 1999-07-06
CA2208374A1 (en) 1996-06-27
AU4450596A (en) 1996-07-10
NZ298826A (en) 1998-10-28
DE69506007D1 (de) 1998-12-17
PL320883A1 (en) 1997-11-10
DK0800386T3 (da) 1999-07-26
HUT77384A (hu) 1998-04-28
FI972542A0 (fi) 1997-06-16
CN1072929C (zh) 2001-10-17
EP0800386A1 (de) 1997-10-15
CN1170359A (zh) 1998-01-14
SK280631B6 (sk) 2000-05-16
ES2125679T3 (es) 1999-03-01
FR2728463B1 (de) 1997-02-21
RU2157193C2 (ru) 2000-10-10
DE69506007T2 (de) 1999-06-10
FI972542A (fi) 1997-06-16
EP0800386B1 (de) 1998-11-11
NO972467D0 (no) 1997-05-30
PL182452B1 (pl) 2002-01-31

Similar Documents

Publication Publication Date Title
AU692042B2 (en) Transdermal system for the simultaneous delivery of a number of active principles
IL131561A0 (en) The use of buprenorphine in the preparation of a medicament for treating pain
MXPA02008403A (es) Mejoras en o relacionadas con el suministro de farmacos por via oral.
PT99513A (pt) Processo para a preparacao de composicoes farmaceuticas contendo profarmacos de morfina para administracao topica por via transdermica
TW359613B (en) Tricot-like pouch for the delivery of topical drugs and cosmetics
IL108234A0 (en) Pharmaceutical composition containing galanthamine
TW347339B (en) Oral delivery of discrete units
BG103552A (en) Therapeutical forms
RU97112182A (ru) Трансдермальная система для одновременной дачи нескольких активных начал
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
GR3033301T3 (en) Medicament form for the delivery of active substances to wounds
PL315127A1 (en) Deuterised biologically active substances for percutaneous administration
PL348202A1 (en) Pharmaceutically active composition and dispensing device
DE69814669D1 (de) Pharmaceutische Zusammensetzung enthaltend (+)-EPHEDRIN und einen H1 Rezeptor Antagonisten
IL140730A0 (en) Blister pack containing transdermal therapeutic systems
GEP20043253B (en) Progestin Therapy with Controlled Bleeding
HUP9701051A2 (hu) Természetes hatóanyagú, gyógyhatású készítmények

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20051219